Information  X 
Enter a valid email address

i-nexus Global PLC (INX)

  Print      Mail a friend

Thursday 19 March, 2020

i-nexus Global PLC

Update re: AGM Procedure

RNS Number : 7916G
i-nexus Global PLC
19 March 2020
 

 

i-nexus Global plc

("i-nexus", the "Company" or the "Group")

 

Update re: AGM Procedure

i-nexus Global plc (AIM: INX), a provider of cloud-based Strategy Execution software solutions for the Global 5000, provides an update on its upcoming annual general meeting (the "AGM"), scheduled to be held at 11.00 a.m. on Monday 23 March 2020 at i-nexus, George House, Herald Avenue, Coventry, CV5 6UB. The health and safety of the Company's shareholders, employees and directors is of paramount importance and so in light of the increased risk posed by the spread of the COVID-19 pandemic, i-nexus sets out details of the precautionary measures to be taken in respect of the AGM.

The AGM will still take place as scheduled, however the Company strongly encourages shareholders to consider whether their attendance in person is strictly necessary. Shareholders are instead being urged to appoint the Chairman as their proxy rather than attend the AGM in person. The deadline for submission of proxies to the Company's registrar, Share Registrars Limited at The Courtyard, 17 West Street, Farnham, Surrey, GU9 7DR, is 11.00 a.m. on 20 March 2020.

The AGM will be concluded swiftly and those still choosing to attend in person following conclusion of the formal business of the meeting will be asked to vacate the AGM venue immediately and will not be invited to ask questions. Professional advisers have been asked not to attend the AGM in person. These measures are being adopted to safeguard the health of those for whom attendance in person is unavoidable, and to ensure the AGM is as safe and efficient as possible.

Shareholders are instead being offered the opportunity to observe and pose questions to the AGM remotely, using the following telephone conference call details:

Telephone number: +44 (0) 203 321 5262

Conference ID number: 205106431

Those wishing to attend the AGM remotely should dial the above telephone number and input the conference ID number to their telephone keypad when prompted. The conference call line will be open from 10:45 a.m. on Monday 23 March 2020 and the AGM will commence as scheduled at 11.00 a.m.

 

For further information please contact:

 

i-nexus Global plc

N+1 Singer (Nominated Adviser and Broker)

Alma PR

Via: Alma PR

Tel: +44 (0)207 496 3000

Tel: +44 (0)203 405 0205

Simon Crowther, CEO

Alyson Levett, CFO

Lauren Kettle (Corporate Finance)

Tom Salvesen (Corporate Broking)

Caroline Forde

Josh Royston

 

About i-nexus Group plc

 

i-nexus supports some of the largest global companies in running, improving and changing their businesses through the provision of a scalable, enterprise-grade, cloud-based Continuous Improvement ("CI") and Strategy Execution ("SE") software platform. The platform is in use at global blue-chip businesses, predominantly based across the US and Europe, helping customers execute key strategic goals throughout all levels and divisions of their organisations.

 

The Group's software supports Hoshin Kanri, a strategy development methodology first introduced in the 1960s in Japan and born out of lean, six sigma and operational improvement theory. Hoshin Kanri (directly translated as "direction execution") is a systematic planning, implementation and review methodology which, when implemented, aims to ensure that the strategic goals of a company are properly communicated to all employees and that they drive progress and action at every level of the business.

 

i-nexus is headquartered in Coventry, UK with a sales office in New York, and employs over 70 staff. 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NOAFLFVIVFIALII

a d v e r t i s e m e n t